You Are Leaving

You have chosen to visit another Lundbeck website or a third-party website, which is provided as a service to you. Lundbeck does not control content on third-party websites and cannot make representations concerning the accuracy of information on every website you visit. Lundbeck is not responsible for the privacy policy of any third-party website. We encourage you to read the privacy policy of every website you visit.

Click here to proceed


About Us

Lundbeck is a Global Pharmaceutical Company Specialized in Brain Diseases

We are tirelessly dedicated to restoring brain health, so every person can be their best. To fulfill this purpose, Lundbeck is engaged in the research, development, manufacturing and commercialization of pharmaceuticals across the world. For more than 70 years, Lundbeck has been at the forefront of neuroscience research.

Our Commitment

Beyond developing new and improved medical therapies, we commit to empowering patients, challenging the status quo, helping families and strengthening communities.

This is Lundbeck

One of the only biopharmaceutical companies in the world focusing exclusively on brain diseases, recognized for having helped hundreds of millions of people with brain diseases.

Our Strategy

Lundbeck’s strategy, “Expand and Invest to Grow,” announced in 2019, builds on Lundbeck’s heritage of delivering essential medicines for brain diseases, leveraging our broad neuroscience expertise to expand the scope of brain diseases we are pursuing for the benefit of patients. 

At Lundbeck, we have a two-tier management structure consisting of our Board of Directors and Executive Management.